Hong Kong Stock Market News:

1) New stock listing

$Midea Group Co. Ltd. (810542.HK)$ Expected to be listed on September 17, with a lineup of luxury cornerstones such as the National Investment Fund (Phase II)

Earlier reports suggested that the financing scale of Midea Group may become the largest IPO project in Hong Kong this year.

2) Company news.

$GAC GROUP (02238.HK)$: The cumulative sales volume from January to August was 1.1524 million vehicles, a year-on-year decrease of 25.68%; the August car sales volume was 0.1482 million vehicles, a year-on-year decrease of 24.69%.

$POLY PROPERTY (00119.HK)$: The cumulative contract sales in the first eight months amounted to 36.8 billion yuan, a decrease of 13.6% compared to the same period last year.

$SEAZEN (01030.HK)$: The cumulative contract sales in the first eight months amounted to 29.542 billion yuan, a decrease of 45.75% compared to the same period last year.

$SHIMAO GROUP (00813.HK)$: The cumulative contract sales in the first eight months amounted to 22.41 billion yuan.

$ZHONGLIANG HLDG (02772.HK)$: The cumulative contract sales in the first eight months amounted to 12.32 billion yuan, a decrease of 51.25% compared to the same period last year.

$RSUN PPT (01996.HK)$In the first eight months, the cumulative contract sales were 6.07 billion yuan, a decrease of 64.11% year-on-year.

$TIMES CHINA (01233.HK)$In the first eight months, the cumulative contract sales were 5.696 billion yuan, a decrease of 49% year-on-year.

$CHINA GLASS (03300.HK)$Intends to invest approximately $17.7095 million to acquire the land use right of a piece of land in Egypt.

$YANCOAL AUS (03668.HK)$Will be included from September 23.$S&P/ASX 200 (.XJO.AU)$And.$S&P/ASX 300 (.XKO.AU)$Index

$SKB BIO-B (06990.HK)$: The research results of the core product Lucaniximab TESIRI-MPTA (sac-TMT) will be released at the 2024 European Oncology Congress.

$AKESO (09926.HK)$: PFS HR 0.51, mPFS 11.14 months IVOSIDAN compared with the treatment of PD-L1 positive NSCLC with Pavolizumab in 1L (AK112-303/HARMONI-2) phase III data released.

$ALPHAMAB-B (09966.HK)$: The latest progress of the Phase III clinical trial of KN046 for the treatment of advanced squamous NSCLC.

3) Buyback Dynamics

$LIAONING PORT (02880.HK)$: Planning to repurchase A-shares with a total amount of 0.42 billion yuan to 0.84 billion yuan.

According to the calculated repurchase price of RMB 1.87 per share, the quantity of shares repurchased by the company in this repurchase is approximately 224.5989-449.1979 million shares, accounting for 0.94%-1.87% of the company's current total share capital.

$HSBC HOLDINGS (00005.HK)$: On September 5th, spent 0.174 billion Hong Kong dollars to repurchase 2.5952 million shares at a repurchase price of 66.95-67.5 Hong Kong dollars.

$BABA-W (09988.HK)$On September 5, it spent $59.9825 million to repurchase 5.8304 million shares at a repurchase price of $10.25-10.38 per share.

Focus on hotspots:

• Non-farm data "upset the game", with the Nasdaq falling 2.5% and leading the three major indexes.

Last Friday, non-farm data shook the financial markets, and the three major indexes collectively fell more than 1%, with the Nasdaq falling more than 2.5%.

Large technology stocks declined across the board, with Tesla down 8.45%, Nvidia down 4.09%, Alphabet C down 4.08%, Amazon down 3.65%, Meta down 3.21%, and Microsoft down 1.64%, with a total market value below $3 trillion. Apple fell 0.70%.

• At 1:00 a.m. Beijing time on September 10, Apple's press conference will debut.

Chinese investors will usher in the latest generation of iPhone, AirPods, and Apple Watch updates at 1:00 a.m. Beijing time on Tuesday. Well-known Apple whistleblower Mark Gurman pointed out that Apple will launch four smart phones: iPhone 16, 16 Plus, 16 Pro, and 16 Pro Max.

These new phones will be equipped with 8GB of memory and upgraded processors, with improvements to their appearance and camera performance. In addition, software updates, particularly the 'Apple Smart' technology, may be the focus or cause heated discussions at this launch event.

• Three departments propose to allow nine cities including Beijing, Tianjin, and Shanghai to establish wholly foreign-owned hospitals.

The Ministry of Commerce, the National Health Commission, and the National Medical Products Administration issued a notice on the pilot work of expanding opening-up in the medical field, which mentioned that it is proposed to allow the establishment of wholly foreign-owned hospitals (excluding Chinese medicine and excluding the acquisition of public hospitals) in Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen, and the entire island of Hainan. The specific conditions, requirements, and procedures for the establishment of wholly foreign-owned hospitals will be notified separately.

• Continuing hot trend! Technology stocks lead the share buyback wave after the interim report season for Hong Kong Stock Exchange.

With the end of the interim report season for Hong Kong Stock Exchange, the buyback market has become active again, and many industry leaders have launched large-scale buyback plans. The on-market buyback trend remains hot. Specifically, $TENCENT (00700.HK)$ Still the undisputed king in the Hong Kong stock repurchase market, as of September 5, Tencent's total repurchase amount this year is approximately HKD 76.4 billion. In addition, among the top ten companies in terms of repurchase scale during the same period, Tencent ranks among them. $MEITUAN-W (03690.HK)$Please use your Futubull account to access the feature.$KUAISHOU-W (01024.HK)$Please use your Futubull account to access the feature.$XIAOMI-W (01810.HK)$

Editor/Somer